Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis
Authors
Keywords
Multiple Sclerosis, Attention Deficit Hyperactivity Disorder, Multiple Sclerosis Patient, Cognitive Dysfunction, Expand Disability Status Scale
Journal
CNS DRUGS
Volume 30, Issue 3, Pages 209-225
Publisher
Springer Nature
Online
2016-02-16
DOI
10.1007/s40263-016-0319-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection
- (2015) J. Correale et al. ACTA NEUROLOGICA SCANDINAVICA
- Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study
- (2015) Carolyn E. Schwartz et al. BMC Neurology
- Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil
- (2015) Carina T. Spedo et al. CLINICAL NEUROPSYCHOLOGIST
- Cognitive impairment and memory disorders in relapsing–remitting multiple sclerosis: the role of white matter, gray matter and hippocampus
- (2015) R. Sacco et al. JOURNAL OF NEUROLOGY
- Negative work events reported online precede job loss in multiple sclerosis
- (2015) Seth E. Frndak et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
- (2015) Maria A Rocca et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- What to make of cannabis and cognition in MS: In search of clarity amidst the haze
- (2015) Anthony Feinstein et al. Multiple Sclerosis Journal
- Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis
- (2015) Claire M Modica et al. Multiple Sclerosis Journal
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy ofGinkgo bilobaextract EGb 761®in dementia with behavioural and psychological symptoms: A systematic review
- (2015) Armin von Gunten et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- What to make of cannabis and cognition in MS: In search of clarity amidst the haze
- (2015) Anthony Feinstein et al. Multiple Sclerosis Journal
- Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis
- (2015) Claire M Modica et al. Multiple Sclerosis Journal
- The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population
- (2014) Benedetta Goretti et al. BMC Neurology
- Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden
- (2014) Helga Westerlind et al. BRAIN
- Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis
- (2014) Vahid Shaygannejad et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Isolated cognitive relapses in multiple sclerosis
- (2014) M. Pardini et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial
- (2014) David M. Erlanger et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Characterizing cognitive function during relapse in multiple sclerosis
- (2014) Ralph HB Benedict et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of cancer in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS
- (2014) J. F. Sumowski et al. NEUROLOGY
- Disease-specific molecular events in cortical multiple sclerosis lesions
- (2013) Marie Therese Fischer et al. BRAIN
- Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis
- (2013) Adam J. Booth et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients
- (2013) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial
- (2013) MP Amato et al. Multiple Sclerosis Journal
- An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial
- (2013) N. D. Chiaravalloti et al. NEUROLOGY
- The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects
- (2013) A. Minagar et al. NEUROLOGY
- Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world
- (2013) M. D. Goldman et al. NEUROLOGY
- Grey matter damage in multiple sclerosis
- (2013) Roel Klaver et al. Prion
- Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
- (2012) Ralph HB Benedict et al. BMC Neurology
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- (2012) J. Corey-Bloom et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)
- (2012) Arman Eshaghi et al. CLINICAL NEUROPSYCHOLOGIST
- Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
- (2012) Jana Blahova Dusankova et al. CLINICAL NEUROPSYCHOLOGIST
- Treatment of cognitive impairment in multiple sclerosis: position paper
- (2012) Maria Pia Amato et al. JOURNAL OF NEUROLOGY
- Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study
- (2012) Sarah A. Morrow et al. JOURNAL OF NEUROLOGY
- Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
- (2012) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Cognitive reserve in ageing and Alzheimer's disease
- (2012) Yaakov Stern LANCET NEUROLOGY
- Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients
- (2012) M Mäurer et al. Multiple Sclerosis Journal
- Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?
- (2012) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis
- (2012) Iris-Katharina Penner et al. Multiple Sclerosis Journal
- Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures
- (2012) D Ontaneda et al. Multiple Sclerosis Journal
- Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
- (2012) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study
- (2012) Vahid Shaygannejad et al. NEUROLOGICAL RESEARCH
- Subcortical atrophy and cognition: Sex effects in multiple sclerosis
- (2012) M. M. Schoonheim et al. NEUROLOGY
- Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial
- (2012) J. F. Lovera et al. NEUROLOGY
- Work Productivity in Relapsing Multiple Sclerosis: Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life
- (2012) Bonnie I. Glanz et al. VALUE IN HEALTH
- Factors related to difficulties with employment in patients with multiple sclerosis
- (2012) Silvia Schiavolin et al. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
- Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?
- (2011) O. Carmona et al. ACTA NEUROLOGICA SCANDINAVICA
- Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2011) P. E. Polak et al. BRAIN
- APOE ε4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis
- (2011) Jiong Shi et al. Cognitive and Behavioral Neurology
- Cognition in multiple sclerosis
- (2011) Dawn W Langdon CURRENT OPINION IN NEUROLOGY
- Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
- (2011) Bianca Weinstock-Guttman et al. JOURNAL OF NEUROLOGY
- Effects of acute relapses on neuropsychological status in multiple sclerosis patients
- (2011) S. A. Morrow et al. JOURNAL OF NEUROLOGY
- Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis
- (2011) Sonia Batista et al. JOURNAL OF NEUROLOGY
- HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis
- (2011) F Möller et al. Multiple Sclerosis Journal
- Unemployment in multiple sclerosis: the contribution of personality and disease
- (2011) Lauren B Strober et al. Multiple Sclerosis Journal
- L-amphetamine improves memory in MS patients with objective memory impairment
- (2011) James F Sumowski et al. Multiple Sclerosis Journal
- Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
- (2011) DW Langdon et al. Multiple Sclerosis Journal
- Risk factors for and management of cognitive dysfunction in multiple sclerosis
- (2011) Ralph H. B. Benedict et al. Nature Reviews Neurology
- Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis
- (2011) L. B. Krupp et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- APOE and risk of cognitive impairment in multiple sclerosis
- (2010) R. I. Oliveri et al. ACTA NEUROLOGICA SCANDINAVICA
- The genetic basis of multiple sclerosis: a model for MS susceptibility
- (2010) Douglas S Goodin BMC Neurology
- Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline
- (2010) Sarah A. Morrow et al. CLINICAL NEUROPSYCHOLOGIST
- Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration
- (2010) Wafaa Zaaraoui et al. JOURNAL OF NEUROLOGY
- Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients
- (2010) RALPH H.B. BENEDICT et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study
- (2010) VM Anderson et al. Multiple Sclerosis Journal
- Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
- (2010) JF Lovera et al. Multiple Sclerosis Journal
- Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
- (2010) SA Morrow et al. Multiple Sclerosis Journal
- Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study
- (2010) CCH Pfleger et al. Multiple Sclerosis Journal
- Cognitive impairment in early stages of multiple sclerosis
- (2010) Maria Pia Amato et al. NEUROLOGICAL SCIENCES
- The contribution of MRI in assessing cognitive impairment in multiple sclerosis
- (2010) M. Filippi et al. NEUROLOGY
- Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis.
- (2010) Sarah W. Kinsinger et al. NEUROPSYCHOLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Sclerosis With Predominant, Severe Cognitive Impairment
- (2009) Nathan P. Staff et al. ARCHIVES OF NEUROLOGY
- Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential
- (2009) Christine Lebrun ARCHIVES OF NEUROLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Sex ratio of multiple sclerosis and clinical phenotype
- (2009) S. V. Ramagopalan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Modafinil effects in multiple sclerosis patients with fatigue
- (2009) Rüdiger Lange et al. JOURNAL OF NEUROLOGY
- The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial
- (2009) Sarah A. Morrow et al. JOURNAL OF NEUROLOGY
- Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis
- (2009) JAMES F. SUMOWSKI et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis
- (2009) F. Patti et al. Multiple Sclerosis Journal
- Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
- (2009) SA Morrow et al. Multiple Sclerosis Journal
- Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes
- (2009) Valentina Zipoli et al. Multiple Sclerosis Journal
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
- (2009) Philip L De Jager et al. NATURE GENETICS
- Regional hippocampal atrophy in multiple sclerosis
- (2008) N. L. Sicotte et al. BRAIN
- Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients
- (2008) R. H. B. Benedict et al. JOURNAL OF NEUROLOGY
- Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy
- (2008) R H B Benedict et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Depression in multiple sclerosis: Review and theoretical proposal
- (2008) PETER A. ARNETT et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process
- (2008) Yermi Harel et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Cognitive impairment in multiple sclerosis
- (2008) Nancy D Chiaravalloti et al. LANCET NEUROLOGY
- Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
- (2008) RHB Benedict et al. Multiple Sclerosis Journal
- Memantine induces reversible neurologic impairment in patients with MS
- (2008) P. Villoslada et al. NEUROLOGY
- Cognitive impairment and structural brain damage in benign multiple sclerosis
- (2008) M. Rovaris et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More